Who Paid My Doc
Shishuka Malhotra
Psychiatry Canton, OH Medical Doctor
NPI 1578582649 CMS profile 25395
4825 Higbee Ave Nw, Suite 120, Canton, OH 44718
General payments
$3,871
Research payments
$221,374
Ownership & investment interest
$0
Research they led as principal investigator
$15,036,298
Through program year 2025, Shishuka Malhotra of Canton, OH is reported in the CMS Open Payments database as having received $3,871 across 62 general payments and $221,374 in research payments paid to them. Separately, studies naming them as principal investigator received $15,036,298 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $71 | 1 | |
| 2024 | General | $1,388 | 4 | |
| 2023 | Research | $4,855 | 6 | |
| 2022 | General | $161 | 9 | |
| 2022 | Research | $17,440 | 5 | |
| 2021 | General | $263 | 14 | |
| 2021 | Research | $3,500 | 1 | |
| 2020 | General | $176 | 10 | |
| 2019 | General | $1,811 | 24 | |
| 2019 | Research | $195,579 | 7 |
Beside peers
- Shishuka Malhotra
- Psychiatry median
- Middle half of Psychiatry
- National median
In program year 2025, general payments to Shishuka Malhotra were reported at $71. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.
Show as a table
| Year | Shishuka Malhotra | Psychiatry median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,811 | $184 | $59–$605 | $163 |
| 2020 | $176 | $119 | $36–$372 | $114 |
| 2021 | $263 | $143 | $43–$576 | $132 |
| 2022 | $161 | $153 | $50–$590 | $149 |
| 2023 | $0 | $170 | $56–$651 | $160 |
| 2024 | $1,388 | $179 | $57–$673 | $164 |
| 2025 | $71 | $180 | $58–$685 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
33
Drug cost
$123
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Zolpidem Tartrate | Generic | 18 | $104 | |
| Lorazepam | Generic | 15 | $19 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,755 Part D prescribers listed as Psychiatry & Neurology; they describe a distribution and say nothing about conduct.
Records
81 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Psychiatry in Ohio
Related records
Psychiatry in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Psychiatry
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.